Kesin Pharma Logo (Kesin Logo)
Lacosamide Oral Solution
Product Images NDC 81033-428
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 81033-428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kesin Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Kesin Pharma Logo (Kesin Logo)
Lacosamide Os 10 mg/ml Bottle Label (Lacosamide Os Bottle 10mg 200ml)
Label for Lacosamide Oral Solution, USP 10 mg/mL, a human prescription drug in oral solution form. The label includes storage instructions, dosage note, and warnings. It indicates the product is distributed by Kesin Pharma Corporation, Oldsmar, FL, with a bottle size of 200 mL and an NDC of 81033-428-02.*
Lacofig1 (Laco Fig 1)
A bar graph titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose.' It compares seizure reduction percentages among placebo and various doses of lacosamide (200, 400, 600 mg/day) across three studies. Seizure reduction percentages increase with lacosamide dose in all studies, with the highest reductions around 40%. Statistically significant differences from placebo are indicated.*
Lacofig2a (Laco Fig 2a)
A cumulative responder rate chart showing the proportion of patients by responder rate for Lacosamide Oral Solution at doses 200 mg/day, 400 mg/day, 600 mg/day, and placebo groups from studies 2, 3, and 4. The X-axis denotes the percent of patients, and the Y-axis shows the responder rate from worsening to improvement.*
Lacostructure (Laco Structur)
Chemical structure diagram of lacosamide, the active ingredient in Lacosamide Oral Solution 10 mg/mL by Kesin Pharma Corporation, showing atoms and bonds forming the molecular framework.*
Lacofig3 (Lacofig3)
A Kaplan-Meier survival curve graph comparing the proportion of patients over time (days) between a placebo group and a lacosamide group. The graph shows two survival lines, one for placebo and one for lacosamide, with corresponding numbers at risk noted below the time axis. Statistical values such as p-value, hazard ratio, and confidence interval are displayed on the graph.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
